Ascidian Therapeutics

Ascidian Therapeutics is a biotechnology company focused on developing RNA-based therapies to treat genetic diseases. They leverage their proprietary RNA exon editing technology to correct mutations at the RNA level, offering a novel approach to gene therapy. Founded in 2020, the company aims to address diseases that currently have limited treatment options. Their innovative platform has the potential to transform the landscape of genetic medicine, making them a significant player in the biotech industry.

Recent Posts by Ascidian Therapeutics

1-2 of 2